pharma · Activated Phosphoinositide 3-Kinase Delta Syndrome · primary immunodeficiency
Pharming Technologies
Pharming Technologies B.V.
News and analysis for Pharming Technologies on NovaPharmaNews — regulatory, clinical, and market coverage.
Leiden, NL HQ
6 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Leiden, NL
- Employees
- 6
- Programs
- 8
- Drugs
- 11
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Pharming Technologies — regulatory, clinical, and market coverage.
News and analysis for Pharming Technologies on NovaPharmaNews — regulatory, clinical, and market coverage.